Why Attend the Congress?
As always, the Congress will be in a focused format to allow concrete issues to be tackled and to have a dialogue with our policymakers, and is a follow-on from our past two successful editions in Belfast and Milan, as well as seven well-attended and influential annual conferences
More than 1000 Life Sciences will convene and, as in the past two years, the event will bring together key audiences who contribute to the vast programme content and vital knowledge exchange.
This year, Congress will be reacting to Brexit, the European Parliament elections and the installation of a new College of Commissioners.
The latter two will, as ever, be tasked with devising and implementing regulatory frameworks in all areas, including certain aspects of health.
One of the goals of Congress is to engage politicians and lawmakers in the fast-growing field of personalised medicine, and deliver political asks through our consensus-based process.
Europe needs to grasp the fact that health equals wealth and that investment in research and innovation, alongside laws and rules that are fit-for-purpose and reflect the swiftly changing world of medicine, are vital. Hence our continued interaction with MEPs, Commissioners and Member State health leaders.
EAPM also aims to showcase developments and new ideas at Congress. For example, development of major initiatives in genomics and personalised medicine is a global trend with significant investments being committed, for example by the governments of the US and China.
Don’t miss the opportunity to join large numbers of industry professionals, government regulators, patients, academia, and exhibitors to drive insights to action.
Strong Reasons to Attend the Congress?
Brussels will see a multi-stakeholder driven Congress with patients at the centre.
The EAPM Congress is a providing thought leadership content and a global platform for healthcare product development and knowledge exchange designed to drive change and improve outcomes.
It’s an opportunity to learn more the scientific, research and policy development in personalised medicine, its huge potential and how it can change the lives of millions of patients for the better
Attendees have the chance to hear the opinions of experts first hand and engage with European, national and regional politicians, as well as respond to and pose questions on the day